Core C provides a critical means by which the PPG will achieve its goals of understanding the in vivo functions of pathways in the B7:CD28 family individually, the interactions among these pathways, and their roles in regulating the balance between pathogenic and protective T cells in lymphoid and non-lymphoid organs. This Core will provide PPG investigators with an important and unique collection of mouse strains for the analysis of pathways in the B7:CD28 family in vivo and has the expertise with both conventional and conditional transgenic and knockout technology that will enable the generation of novel mouse strains for analyzing the functions of these pathways in vivo.
Our specific aims are: 1) To generate novel mouse strains lacking CD28 or B7 family members, conditionally or inducibly, 2) To generate transgenic strains that overexpress B7:CD28 family members, either constitutively or inducibly 3) To generate mouse strains that facilitate the analysis of interactions between negative regulatory receptors or the interplay between positive and negative second signals in the B7:CD28 family, 4) To generate mouse strains that facilitate the analysis of roles of B7:CD28 family members in regulating the balance between protective and pathogenic immune responses by breeding mice lacking or overexpressing B7 or CD28 family members with cytokine, cytokine receptor, and FoxP3 reporter strains, and 5) To maintain and provide mice of existing transgenic and knockout strains to PPG investigators. Core C will work closely with project investigators, not only to provide them with transgenic and knockout strains, but also to generate novel strains based upon their findings in PPG projects. Core C also will provide mice lacking B7 and CD28 family members to Core B for the generation of novel mAbs and transgenic mice for studies aimed at evaluating agonistic Ig fusion proteins and mAbs that deliver a negative signal. Taken together, these activities of Core C will provide PPG investigators with novel mouse strains for studying the roles of pathways in the B7:CD28 family in controlling T cell responses in mouse models of transplantation, autoimmunity, and infection. These studies will not only provide insights into the roles of these pathways in regulating T cell activation and tolerance in vivo, but also may provide information critical for therapeutic manipulation of these key immunoregulatory pathways.
These studies will provide the basis for understanding how, where and when costimulatory molecules regulate allograft rejection, organ-specific autoimmune diseases, and chronic viral infection These studies have implications for developing costimulation-based therapies for human chronic viral infections, cancer, autoimmune diseases and alloresponses that limit hematopoietic and solid organ allograft acceptance.
|Xu, Jie; Sun, Heather H; Fletcher, Christopher D M et al. (2016) Expression of Programmed Cell Death 1 Ligands (PD-L1 and PD-L2) in Histiocytic and Dendritic Cell Disorders. Am J Surg Pathol 40:443-53|
|Borges, Christopher M; Reichenbach, Dawn K; Kim, Beom Seok et al. (2016) Regulatory T cell expressed MyD88 is critical for prolongation of allograft survival. Transpl Int 29:930-40|
|Chapuy, Bjoern; Roemer, Margaretha G M; Stewart, Chip et al. (2016) Targetable genetic features of primary testicular and primary central nervous system lymphomas. Blood 127:869-81|
|Schildberg, Frank A; Klein, Sarah R; Freeman, Gordon J et al. (2016) Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family. Immunity 44:955-72|
|SchÃ¶nle, Anne; Hartl, Frederike A; Mentzel, Jan et al. (2016) Caveolin-1 regulates TCR signal strength and regulatory T-cell differentiation into alloreactive T cells. Blood 127:1930-9|
|Flynn, Ryan; Paz, Katelyn; Du, Jing et al. (2016) Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism. Blood 127:2144-54|
|Zeiser, Robert; Blazar, Bruce R (2016) Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation? Blood 127:3117-26|
|Hirakawa, Masahiro; Matos, Tiago; Liu, Hongye et al. (2016) Low-dose IL-2 selectively activates subsets of CD4(+) Tregs and NK cells. JCI Insight 1:e89278|
|Li, Wei; Liu, Liangyi; Gomez, Aurelie et al. (2016) Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease. JCI Insight 1:|
|Lo, Tsun-Ho; Silveira, Pablo A; Fromm, Phillip D et al. (2016) Characterization of the Expression and Function of the C-Type Lectin Receptor CD302 in Mice and Humans Reveals a Role in Dendritic Cell Migration. J Immunol 197:885-98|
Showing the most recent 10 out of 257 publications